(Q37998191)

26 August 2017

Expanding roles of glutamate receptors in neurovascular regulation (English)

1 reference

26 August 2017

J S Alexander

1

1 reference

PubMed ID

22459074

26 August 2017

Chaitanya V Ganta

series ordinal

2

1 reference

26 August 2017

20 March 2012

1 reference

26 August 2017

Vascular Pharmacology

1 reference

26 August 2017

57

1 reference

26 August 2017

1

1 reference

26 August 2017

1-2

1 reference

Activation of neuroprotective pathways by metabotropic group I glutamate receptors: a potential target for drug discovery?

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

Metabotropic glutamate receptor 5 mediates phosphorylation of vascular endothelial cadherin and nuclear localization of β-catenin in response to homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

Oxidative stress upregulates the NMDA receptor on cerebrovascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

Claudin-5 expression in in vitro models of the blood-brain barrier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

Antibodies preventing the interaction of tissue-type plasminogen activator with N-methyl-D-aspartate receptors reduce stroke damages and extend the therapeutic window of thrombolysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

tPA regulates pulmonary vascular activity through NMDA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

Urokinase plasminogen activator regulates pulmonary arterial contractility and vascular permeability in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

Effects of NMDA receptor modulators on a blood-brain barrier in vitro model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

Human Neuroepithelial Cells Express NMDA Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

N-methyl-D-aspartate receptor activation in human cerebral endothelium promotes intracellular oxidant stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.03.004

10.1016/J.VPH.2012.03.004

7 January 2021

Identifiers

DOI

1 reference

release_4rn2lr6vebbehcheenkx6ltivu

26 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4rn2lr6vebbehcheenkx6ltivu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

22459074

1 reference

PubMed ID

22459074